CAS 2097132-93-7

(1r,4r)-N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}cyclohexane-1-carboxamide

CAS : 2097132-93-7

(1r,4r)-N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}cyclohexane-1-carboxamide

Formule : C₂₇H₃₂FN₉O₂

Degré de pureté : ≥95%

Masse moléculaire : 533.6

Ref: 54-PC1030638

trans-Pralsetinib

CAS : 2097132-93-7

trans-Pralsetinib (trans-BLU-667) is a RET inhibitor. It targets RET kinase to suppress tumor growth driven by RET mutations or rearrangements; used in lung and thyroid cancer research.

Formule : C₂₇H₃₂FN₉O₂

Degré de pureté : 98.06%

Couleur et forme : Transparent Viscous

Masse moléculaire : 533.6

Ref: TM-T10823